Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor

In only two years, the coronavirus disease 2019 (COVID-19) pandemic has had a devastating effect on public health all over the world and caused irreparable economic damage across all countries. Due to the limited therapeutic management of COVID-19 and the lack of tailor-made antiviral agents, findin...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Veronika Nemethova, Petra Mazancova, Michal Selc, Kristina Jakic, Lucia Uhelska, Boglarka Nemethova, Alexandra Poturnayova, Lubos Drgona, Andrea Babelova, Filip Razga
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2022-03-01
Collection:Viruses
Sujets:
SARS-CoV-2
COVID-19
RNA levels
oligonucleotide-based RNA inhibitor
RdRp
Accès en ligne:https://www.mdpi.com/1999-4915/14/4/685
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires